Landfar Bio-medicine Co., Ltd (SHE:000504)
10.14
+0.07 (0.70%)
Mar 30, 2026, 3:04 PM CST
Landfar Bio-medicine Revenue
Landfar Bio-medicine had revenue of 31.85M CNY in the quarter ending September 30, 2025, a decrease of -11.76%. This brings the company's revenue in the last twelve months to 125.47M, up 0.82% year-over-year. In the year 2024, Landfar Bio-medicine had annual revenue of 134.45M, down -1.71%.
Revenue (ttm)
125.47M
Revenue Growth
+0.82%
P/S Ratio
26.67
Revenue / Employee
331.93K
Employees
378
Market Cap
3.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 134.45M | -2.34M | -1.71% |
| Dec 31, 2023 | 136.79M | -63.55M | -31.72% |
| Dec 31, 2022 | 200.35M | 43.73M | 27.92% |
| Jan 1, 2022 | 156.62M | -18.95M | -10.79% |
| Dec 31, 2020 | 175.56M | 41.40M | 30.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Kawin Technology Share-Holding | 1.15B |
| Guangdong VTR Bio-Tech | 830.87M |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Cabio Biotech (Wuhan) | 574.88M |
| Shanghai Model Organisms Center | 421.26M |
| Yantai Zhenghai Biotechnology | 347.60M |
| Jiangsu Sihuan Bioengineering | 341.90M |